Skip to content

Use of Cashew Nut Flour on children with Human Immunodeficiency Virus

Effect of Cashew Nut Flour Supplementation on the immunological and nutritional status of children infected with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6sf6njs
Enrollment
Unknown
Registered
2023-02-23
Start date
2022-04-04
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human immunodeficiency virus

Interventions

The pairing will be carried out between the experimental and control groups through the previous selection of children with the same characteristics (depending on eligibility criteria), and in this ca
PLOUS, 2013). This is a frequently used technique to ensure an equal distribution of the number of participants in the study groups. In this case, randomization is done in “blocks” of predetermined si
PATINO, 2016). Randomization will proceed normally within each block until the fourth person is randomized to a group
after that, participants will be automatically distributed to the other group, until the block of eight is completed. Blinding will be of the simple type. The experimental and control groups will rece
G07.203.300.456

Sponsors

Ana Cristina Pereira de Jesus Costa
Lead Sponsor
Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão
Collaborator

Eligibility

Age
2 Years to 9 Years

Inclusion criteria

Inclusion criteria: Term birth. Receiving Anti-Retroviral Therapy for HIV for at least ninety days. Preserved kidney and liver function

Exclusion criteria

Exclusion criteria: User of psychotropic or antimicrobial or antineoplastic drug. Have started intervention to recover nutritional status. Have an allergy to cashew nut products

Design outcomes

Primary

MeasureTime frame
Expected to find a mean difference in blood hemoglobin verified through analytical statistics of at least 7g/dL after the intervention.

Secondary

MeasureTime frame
Expected to find a body mass index between the 5th and 85th percentile verified through analytical statistics for each age and gender.

Countries

Brazil

Contacts

Public ContactAna Cristina Pereira de Jesus Costa

Universidade Federal do Maranhão

cristina.ana@ufma.br+55(99)99904-1415

Outcome results

None listed

Source: REBEC (via WHO ICTRP)